.png){kind=logo}
.png){kind=logo}
Nestlé Health Science CEO Don Kerrigan Talks Acquisition Of Vital Proteins And The Company's Future Growth
.webp/fit-in/700x9999/filters:no_upscale())
When Don Kerrigan, a well-versed executive previously serving as the president of Nature’s Bounty, was appointed to be the CEO of Nestlé Health Science U.S. in 2021 as a result of the acquisition of the global nutrition player, he had an ambitious vision for the business — finding more scalable opportunities in CPG sectors where the Swiss conglomerate doesn’t traditionally have a foothold.
When Don Kerrigan, a well-versed executive previously serving as the president of Nature’s Bounty, was appointed to be the CEO of Nestlé Health Science U.S. in 2021 as a result of the acquisition of the global nutrition player, he had an ambitious vision for the business — finding more scalable opportunities in CPG sectors where the Swiss conglomerate doesn’t traditionally have a foothold.
With a growing number of health-focused products available on the market driven by consumers prioritizing food as medicine, Nestlé Health Science has quickly capitalized on the trend, onboarding a handful of better-for-you grocery brands over the years, notably Dr. Andrew Abraham-founded Orgain and Vital Proteins. This portfolio expansion resonates with Kerrigan personally.
.png/fit-in/250x250/filters:no_upscale())
)
){kind=logo}
)
){kind=logo}
)
.png/fit-in/250x250/filters:no_upscale())
)
){kind=logo}
)
){kind=logo}
)
)
)
)
.png/fit-in/250x250/filters:no_upscale())
){kind=logo}
){kind=logo}
)
.png/fit-in/250x250/filters:no_upscale())
)
)
.png/fit-in/250x250/filters:no_upscale())
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)